These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24578536)

  • 1. Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data.
    Hallinen T; Soini EJ; Asseburg C; Kuosmanen P; Laakkonen A
    BMJ Open; 2014 Feb; 4(2):e004071. PubMed ID: 24578536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct costs of warfarin treatment among patients with atrial fibrillation in a Finnish health care setting.
    Hallinen T; Martikainen JA; Soini EJ; Suominen L; Aronkytö T
    Curr Med Res Opin; 2006 Apr; 22(4):683-92. PubMed ID: 16684429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Out-of-range international normalized ratio values and healthcare cost among new warfarin patients with non-valvular atrial fibrillation.
    Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
    J Med Econ; 2015 May; 18(5):333-40. PubMed ID: 25549062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation.
    Deitelzweig S; Evans M; Hillson E; Trocio J; Bruno A; Tan W; Lingohr-Smith M; Singh P; Lin J
    Curr Med Res Opin; 2016; 32(1):87-94. PubMed ID: 26451675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin for atrial fibrillation in community-based practise.
    Rose AJ; Ozonoff A; Henault LE; Hylek EM
    J Thromb Haemost; 2008 Oct; 6(10):1647-54. PubMed ID: 18853483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting.
    Urbonas G; Valius L; Šakalytė G; Petniūnas K; Petniūnienė I
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30650565
    [No Abstract]   [Full Text] [Related]  

  • 7. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort.
    Liu S; Singer A; McAlister FA; Peeler W; Heran BS; Drummond N; Manca DP; Allan GM; Korownyk C; Kolber MR; Greiver M; Garrison SR
    Can Fam Physician; 2019 Jun; 65(6):416-425. PubMed ID: 31189630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
    Pokorney SD; Simon DN; Thomas L; Fonarow GC; Kowey PR; Chang P; Singer DE; Ansell J; Blanco RG; Gersh B; Mahaffey KW; Hylek EM; Go AS; Piccini JP; Peterson ED;
    Am Heart J; 2015 Jul; 170(1):141-8, 148.e1. PubMed ID: 26093875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rivaroxaban versus warfarin on health care costs among nonvalvular atrial fibrillation patients: observations from rivaroxaban users and matched warfarin users.
    Laliberté F; Cloutier M; Crivera C; Nelson WW; Olson WH; Schein J; Vanderpoel J; Germain G; Lefebvre P
    Adv Ther; 2015 Mar; 32(3):216-27. PubMed ID: 25784509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant management of atrial fibrillation: the influence of dosing algorithm and recall schedule on time in therapeutic range.
    Swarna Nantha Y
    Fam Pract; 2015 Oct; 32(5):514-9. PubMed ID: 26251026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden.
    Björholt I; Andersson S; Nilsson GH; Krakau I
    BMC Fam Pract; 2007 Feb; 8():6. PubMed ID: 17324260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
    Singer DE; Hellkamp AS; Piccini JP; Mahaffey KW; Lokhnygina Y; Pan G; Halperin JL; Becker RC; Breithardt G; Hankey GJ; Hacke W; Nessel CC; Patel MR; Califf RM; Fox KA;
    J Am Heart Assoc; 2013 Feb; 2(1):e000067. PubMed ID: 23525418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Warfarin control in Hong Kong clinical practice: a single-centre observational study.
    Lam ASM; Lee IMH; Mak SKS; Yan BPY; Lee VWY
    Hong Kong Med J; 2020 Aug; 26(4):294-303. PubMed ID: 32729553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare resource utilization and costs among nonvalvular atrial fibrillation patients initiating rivaroxaban or warfarin in skilled nursing facilities: a retrospective cohort study.
    Mittal VS; Wu B; Song J; Milentijevic D; Ashton V; Mahajan D
    Curr Med Res Opin; 2020 Apr; 36(4):529-536. PubMed ID: 31858841
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost analysis of a managed care decentralized outpatient pharmacy anticoagulation service.
    Anderson RJ
    J Manag Care Pharm; 2004; 10(2):159-65. PubMed ID: 15032565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of TTR-INR guided warfarin adjustment protocol to improve time in therapeutic range in patients with atrial fibrillation receiving warfarin.
    Kosum P; Siranart N; Nissaipan K; Laohapiboolrattana W; Sowalertrat W; Triamamornwooth K; Arunphan R; Sriyom A; Rungpradubvong V
    Sci Rep; 2024 May; 14(1):11647. PubMed ID: 38773162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring anticoagulation in atrial fibrillation.
    Sarawate C; Sikirica MV; Willey VJ; Bullano MF; Hauch O
    J Thromb Thrombolysis; 2006 Apr; 21(2):191-8. PubMed ID: 16622617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.